Table of Contents Author Guidelines Submit a Manuscript
Journal of Chemistry
Volume 2014, Article ID 278318, 10 pages
http://dx.doi.org/10.1155/2014/278318
Review Article

Pharmacological Activities of Sijunzi Decoction Which Are Related to Its Antioxidant Properties

1Department of Chinese Medicine Integrated with Western Medicine, Binzhou Medical University, Yantai, Shandong 264003, China
2School of Biosciences, Northwest A&F University, Xi’an, Shanxi 710000, China

Received 18 May 2014; Accepted 5 July 2014; Published 23 July 2014

Academic Editor: Qiusheng Zheng

Copyright © 2014 Lei Ye et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

This paper introduces the antioxidant constituents and pharmacological effects of Sijunzi decoction by looking up literatures in recent years. Sijunzi decoction is composed of Ginseng, Atractylodes, Tuckahoe, and Glycyrrhiza. The antioxidant ingredients of Sijunzi decoction include paeonol, dauricine, naringin, and isoliquiritigenin. The study has proved that it possesses wide pharmacological effects of anticardiovascular diseases, antinervous system disease, antidiabetes, antimetabolic syndrome, and antitumor. Research on the antioxidant components of Sijunzi decoction and their targets is a promising study area in the future.

1. Introduction

Phagocytic cells release a significant amount of reactive oxygen species (ROS) through respiratory burst under the stimulus of pathogenic microorganisms when “spleen qi deficiency” occurs, which is often associated with gastrointestinal inflammation. Through NADPH oxidation, ROS can cause oxidative damage and further aggravate the inflammation. Studies have shown that Sijunzi decoction has evident antioxidant effects [1] and can eliminate or reduce biological membrane lipid peroxidation caused by free radicals [2]. Moreover, Sijunzi decoction can increase superoxide dismutase (SOD) activity and reduce MDA generation to speed up the elimination of free radicals and other harmful substances to protect biological macromolecules from damage and improve the DNA repair. Sijunzi decoction has an antioxidant effect because it contains a wide variety of free radical scavenging molecules. These antioxidant compounds possess anti-inflammatory, antiatherosclerotic, antitumor, antimutagenic, anticarcinogenic, or antibacterial properties. The antioxidants derived from Sijunzi decoction are summarized in this study. The source of antioxidants discussed in this study is shown in Table 1.

tab1
Table 1

2. The Role of Antioxidants from Sijunzi Decoction

2.1. Antioxidants of Anticardiovascular Disease

Several components of Sijunzi soup have antioxidant activity and decrease the occurrence of cardiovascular diseases. Studies have shown that isoliquiritigenin, which is a natural antioxidant derived from liquorice, has a significant role in anticardiovascular disease through activation of the AMP-activated protein kinase (AMPK) and ERK signaling pathways and balance of cellular redox status [3]. Naringin derived from liquorice, which is the second most important antioxidant component, inhibits reactive oxygen species- (ROS-) activated MAPK pathway involved in high glucose-induced injuries of H9c2 cardiac cells [4]. Naringin mitigates hypertension and thrombosis by increasing the bioavailability of nitrogen oxide (NO) and protecting the endothelial function from ROS [5]. Moreover, naringin can improve redox-sensitive myocardial ischemia reperfusion injury [6]. Glabridin, which is derived from liquorice and is responsible for its antioxidative characteristics in low-density lipoprotein (LDL) oxidation, is also important [7]. Isorhamnetin, which is also derived from liquorice, can inhibit the H2O2-induced activation of the intrinsic apoptotic pathway through ROS scavenging and ERK inactivation. Therefore, isorhamnetin is a promising reagent for the treatment of ROS-induced cardiomyopathy [8].

Paeonol, which is mainly collected from ginseng, affects the development of cardiovascular tissues. Paeonol has antioxidant and anti-inflammatory properties, which can be developed for use in anti-inflammatory and vascular disorders [9]. The therapeutic mechanism of paeonol prevents monocyte adhesion onto vascular endothelial cells (VECs) induced by ox-LDL [10]. Paeonol has a protective effect on the hypoxia/reoxygenation damage of myocardial cells; therefore, it can prevent myocardial infarction induced by isoproterenol in rats [11]. Paeonol can also decrease oxidative injury and repair blood vessel endothelium, as well as prevent the development of coronary diseases [12].

2.2. Antioxidants against Diabetes and Metabolic Syndrome

Metabolic syndrome is a low-grade inflammatory state, where oxidative stress is involved. Some of the antioxidants extracted from Sijunzi decoction exhibit antidiabetes activities or metabolic syndrome reversal. Isoliquiritigenin can significantly decrease the level of blood glucose [13]. Naringin exhibits significant antidiabetic effects by potentiating the antioxidant defense system and by suppressing proinflammatory cytokine production in a rat model of T2DM [14]. Naringin reverses the metabolic syndrome by decreasing inflammatory cell infiltration and plasma lipids; the process mitigates oxidative stress and improves mitochondrial function [15]. Glabridin, which is a major active flavonoid in Glycyrrhiza glabra (licorice), improves learning and memory in mice. Glabridin reverses learning and memory defects in diabetic rats. Glabridin treatment partially improves the reduced body weight and hyperglycemia of diabetic rats. Their mechanisms may be related to the combination of antioxidant, neuroprotective, and anticholinesterase properties of glabridin [16] or as an activator of AMP-activated protein kinase (AMPK) [17].

2.3. Antioxidants of Antineurological Diseases

Clinically, Sijunzi decoction is often used to treat several neurological diseases. Calycosin, which is derived from licorice, has a neuroprotective effect against cerebral ischemia/reperfusion injury through its antioxidant effects [55]. Isoliquiritigenin protects HT22 hippocampal neuronal cells from oxidative stress-induced glutamate. The mechanisms are related to the reversed ROS production and mitochondrial depolarization induced by glutamate, as well as the regulation expression of the apoptotic regulators, Bcl-2 and Bax [31]. Isoliquiritigenin can protect dopaminergic cells from oxidative injury and prevent Aβ(25–35)-induced neuronal apoptotic death by interfering with the increase of and ROS [32]. Liquiritigenin is derived from licorice; this compound improves behavioral performance and attenuates neuronal loss in the brain of rats [64]. Pinocembrin derived from licorice has a significant role in neurovascular protection by protecting the cerebral ischemia and increasing the viability of the mitochondrial membrane [57, 58, 80, 81]. Pinocembrin abrogates the effects of the neurotoxin 1-methyl-4-phenylpyridinium, which mimics Parkinson’s disease with an elevation of intracellular ROS level and apoptotic death [82]. This phenomenon might be another mechanism for pinocembrin in mitigating nervous system diseases.

Nicotiflorin, which is derived from licorice, markedly reduces brain infarct volume and neurological deficits immediately following its administration after the onset of ischemia. Nicotiflorin also protects against memory dysfunction, energy metabolism failure, oxidative stress in multi-infarct dementia model rats, cerebral ischemic damage, aluminum chloride-induced cognitive dysfunction, and mitochondrial oxidative damage [61, 62]. Investigations about the protective mechanism of kaempferol glycosides showed the involvement of their antioxidative activity, blockage of caspase cascades, attenuation of NMDA-induced neuronal toxicity, inhibition of monoamine oxidase (MAO), excessive NO production, and others [63].

Naringin may be beneficial in mitigating 3-NP-induced neurodegeneration through its antioxidant and antiapoptotic effects [39, 40].

Glabridin has a neuroprotective effect because of the modulation of multiple pathways associated with apoptosis. Glabridin significantly attenuates the level of brain malonyldialdehyde (MDA) in MCAO rats; however, it elevates the levels of two endogenous antioxidants in the brain, namely, SOD and reduced glutathione [48].

Dauricine is derived from ginseng and has cerebral ischemia-reperfusion injury protection effect, which may be related to its inhibition of neuron apoptosis [22]. Paeonol mitigates neuronal damage not only by decreasing ROS overgeneration, but also by regulating expression of apoptosis proteins and neurotrophic factors [18, 19].

2.4. Antioxidants of Antirespiratory Diseases

Three components from Sijunzi soup have significant roles in preventing respiratory diseases.

Naringin has antitussive, anti-AHR, and anti-inflammation effects on chronic cigarette smoke exposure-induced chronic bronchitis in guinea pigs; this compound improves SOD activity in lung tissue and increases the content of lipoxin A4 in bronchoalveolar lavage fluid (BALF) in a guinea pig model for chronic bronchitis [41, 42]. Dauricine induces glutathione depletion and apoptosis in lungs of CD-1 mice and in cultured human lung cells [23]. Liquiritigenin can protect human lung cells (A549) from a hemolysin-mediated injury [65].

2.5. Antioxidants against Digestive System Diseases

Several components of Sijunzi soup are also involved in antidigestive system diseases.

Liquiritigenin has a choleric effect and exhibits the ability to induce hepatic transporters and phase-II enzymes, which are a group of antioxidant systems that function against oxidative stress, carcinogenesis, mutagenesis, and other forms of toxicity [66]. Isoliquiritigenin, which is similar with liquiritigenin, can repress LXRα-dependent hepatic steatosis through JNK1 inhibition and protect hepatocytes from oxidative injury inflicted by fat accumulation [33].

The induction of HO activity by pinocembrin has a protective effect against hepatic damage associated with oxidative stress in rats. Pinocembrin challenges hepatocarcinogens and may exhibit anticarcinogenic effects [59]. Dauricine is subject to oxidative bioactivation in human liver microsomes in vitro and in rats in vivo [24].

Licoflavone, isobavachalcone, and quercetin are derived from licorice. Licoflavone feeding suppresses gastric mucosa injury and protects and restores injured mucosa in rats with chronic superficial gastritis. These effects are related with the upregulation of serum PGE2 levels [69]. Isobavachalcone shows broad antioxidative activities in rat liver microsomes and mitochondria [70]. Quercetin has beneficial effects on liver fibrosis in rats by enhancing antioxidant enzyme activity and reducing the prooxidant effects [79].

Several studies have demonstrated that isorhamnetin is efficient in protecting hepatocytes against oxidative stress by Nrf2 activation and in inducing the expression of its downstream genes [50].

Paeonol can inhibit HSC proliferation and induce mitochondrial apoptosis by disrupting the NF-κB pathway, which is probably the mechanism of paeonol reduction of liver fibrosis [20].

2.6. Antioxidants of Antitumors

Natural compounds isolated from Sijunzi decoction, which are rich sources of novel anticancer drugs, have gained increasing interest.

Isoliquiritigenin significantly inhibits the proliferation of C4-2 prostate cancer cells in IEC-6 normal epithelial cells in vitro, increases intracellular ROS levels, and causes SKOV-3 and hela cell apoptosis [3436]. The prodifferentiation effect of isoliquiritigenin on HL-60, particularly the role of redox homeostasis in regulating HL-60 cell differentiation by modulation of the Nrf2/ARE pathway, has been investigated [37, 38].

Licochalcone A and licochalcone B are derived from licorice. Licochalcone A has potent antitumor effects in prostate, breast, and bladder cancer, as well as in leukemia cell lines [74]. A study has shown that the induction of endoplasmic reticulum stress through a PLC γ1-, Ca2+-, and ROS-dependent pathways may be significant when licochalcone A induces apoptosis in HepG2 hepatocellular carcinoma cells [75]. Furthermore, licochalcone B inhibits the concentration-dependent bladder cancer cell proliferation; this antiproliferative effect is caused by the induction of S-phase arrest and apoptotic cell death [77].

Dauricine can inhibit the proliferation activity of urinary tract tumor cells. By inhibiting the NF-B signaling pathway in colon cancer cells, dauricine inhibits proliferation and invasion of the cancer [25, 26]. Furthermore, dauricine inhibits human breast cancer angiogenesis by suppressing hypoxia inducible factor-1α (HIF-1α) protein accumulation and vascular endothelial growth factor (VEGF) expression [27].

Naringin can induce receptor death and mitochondria-mediated apoptosis in human cervical cancer cells [43]. Naringin reduces the growth potential of human triple-negative breast cancer cells by targeting the β-catenin signaling pathway [44]. Naringin is effective in reducing the number of preneoplastic lesions in rats exposed to 1,2-dimethylhydrazine. Several of these effects may be caused by reduced cellular proliferation and tissue levels of iron and the recovery of antioxidant mineral levels induced by this flavonoid [45].

Pancratistatin is derived from ginseng and may be a novel mitochondria-targeting compound that selectively induces apoptosis in cancer cells and significantly reduces tumor growth [28, 29]. Pancratistatin treatment in cancer cell lines results in increased ROS production and reduction of mitochondrial membrane potential [30]. Morusin, which is derived from licorice, significantly inhibits the growth and clonogenicity of HT-29 human colorectal cancer cells, as well as the human cervical cancer stem cell growth and migration [72, 73].

Calycosin is an indispensable element in antitumor activities. Calycosin inhibits breast cancer growth and is obtained by estrogen receptor (ER) β-mediated regulation of the IGF-1R signaling pathways and miR-375 expression [56]. Isorhamnetin exhibits antioxidant and antiproliferative activities in a variety of cancer cell lines [5153].

Glabridin is a novel anticancer agent for treating breast cancer in three different manners, namely, inhibition of migration, invasion, and angiogenesis [49]. Pinocembrin triggers Bax-dependent mitochondrial apoptosis in colon cancer cells [60]. Isobavachalcone induces apoptotic cell death in neuroblastoma through the mitochondrial pathway and is not cytotoxic against normal cells [71]. Paeonol has significant growth-inhibitory and apoptosis-inducing effects in gastric cancer cells, both in vitro and in vivo [21].

2.7. Antioxidants against Inflammation

The components of Sijunzi soup have a significant role against inflammation.

Naringin is an effective anti-inflammatory compound for attenuating the chronic pulmonary neutrophilic inflammation in CS-induced rats. The oxidative stress caused by cigarette smoke (CS) exposure increases inflammatory cell influxes in the lungs, followed by lipid peroxidation, and increases proinflammatory cytokines, such as the tumor necrosis factor-α [46]. Liquiritigenin has an anti-inflammatory effect, as shown by the inhibition of nitric oxide and tumor necrosis factor-production, which is induced by the lipopolysaccharides in macrophages [67]. Licochalcone A protects BALB/c mice from lipopolysaccharide- (LPS-) induced endotoxin shock by inhibiting the production of inflammatory cytokines and ROS [76]. Quercetin and kaempferol can modulate the degranulation and oxidative burst of stimulated human neutrophils. Rutin, which is derived from licorice, inhibits the primary humoral immune response in mice [78]. The induction of HO-1 by isorhamnetin may reduce ROS production, and the antioxidant property of isorhamnetin might inhibit the COX-2 expression in response to inflammation [54].

2.8. Others

The Sijunzi soup has a significant role in other aspects, such as the mitigation of musculoskeletal diseases and the progression of hematological system diseases.

The modulation of PI3K antioxidant effects and the attenuation of mitochondrial dysfunction by liquiritigenin represent an important mechanism for the protection of osteoblasts against cytotoxicity, which results from mitochondrial oxidative stress [68].

Naringin mitigates erythrocyte aging induced by paclitaxel (PTX), which suggests that naringin inhibits PTX-induced aging by reducing the PTX-induced oxidative stress [47].

3. Antioxidants List

See Tables 1 and 2.

tab2
Table 2

4. Conclusion

The oxidative products of organisms cause several diseases. Several studies have been conducted on the effects of antioxidant-scavenging free radical. Sijunzi decoction contains a variety of antioxidants. The effects of these antioxidants have gained attention from scholars at home and abroad. Various research results have been obtained. The antioxidants in Sijunzi decoction decrease free radical content and enhance the free radical scavenging activities in the body by adjusting the activity of the antioxidative enzyme system when spleen deficiency occurs. The antioxidants in Sijunzi decoction eliminate the peroxidation damage in tissues, cells, and various types of biological macromolecules and protect the normal structure and function of the cell membrane. Sijunzi decoction improves the pathological changes of tissues and cells in the cardiovascular and respiratory systems, corrects the nerve and endocrine functions, strengthens digestion, and induces tumor cell apoptosis. Revealing mainly the antioxidant of Sijunzi decoction is necessary to understand its antioxidant effects. Research to discover the antioxidant components of Sijunzi decoction and their target research are areas of future study in this field.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

References

  1. Y. Wei and W. Li, “The c orrelation of experimental spleen deficiency and free radical metabolism and t he adjustment of sijunzi decoction,” Acta Veterinaria et Zootechnica Sinica, vol. 33, no. 1, pp. l00–104, 2002. View at Google Scholar
  2. W. Yanming and L. Wenguang, “Si Jun Zi decoction anti lipid peroxidation in vitro and the role of reactive oxygen free radicals,” Acta Veterinaria et Zootechnica Sinica, vol. 33, no. 2, pp. 197–199, 2002. View at Google Scholar
  3. X. Zhang, P. Zhu, Y. Ma et al., “Natural antioxidant-isoliquiritigenin ameliorates contractile dysfunction of hypoxic cardiomyocytes via AMPK signaling pathway,” Mediators of Inflammation, vol. 2013, Article ID 390890, 10 pages, 2013. View at Publisher · View at Google Scholar
  4. J. Chen, R. Guo, H. Yan et al., “Naringin inhibits ROS-activated MAPK pathway in high glucose-induced injuries in H9c2 cardiac cells,” Basic & Clinical Pharmacology & Toxicology, vol. 114, no. 4, pp. 293–304, 2014. View at Publisher · View at Google Scholar
  5. M. Ikemura, Y. Sasaki, J. C. Giddings, and J. Yamamoto, “Preventive effects of hesperidin, glucosyl hesperidin and naringin on hypertension and cerebral thrombosis in stroke-prone spontaneously hypertensive Rats,” Phytotherapy Research, vol. 26, no. 9, pp. 1272–1277, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Rani, S. Bharti, M. Manchanda et al., “Regulation of heat shock proteins 27 and 70, p-Akt /p-eNOS and MAPKs by Naringin Dampens myocardial injury and dysfunction in vivo after ischemia/reperfusio,” PLoS ONE, vol. 8, Article ID e82577, 2013. View at Google Scholar
  7. B. Fuhrman, S. Buch, J. Vaya et al., “Licorice extract and its major polyphenol glabridin protect low-density lipoprotein against lipid peroxidation: in vitro and ex vivo studies in humans and in atherosclerotic apolipoprotein E-deficient mice,” The American Journal of Clinical Nutrition, vol. 66, no. 2, pp. 267–275, 1997. View at Google Scholar · View at Scopus
  8. B. Sun, G. Sun, J. Xiao et al., “Isorhamnetin inhibits H2O2-induced activation of the intrinsic apoptotic pathway in H9c2 cardiomyocytes through scavenging reactive oxygen species and ERK inactivation,” Journal of Cellular Biochemistry, vol. 113, no. 2, pp. 473–485, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. L. L. Pan and M. Dai, “Paeonol from Paeonia suffruticosa prevents TNF-α-induced monocytic cell adhesion to rat aortic endothelial cells by suppression of VCAM-1 expression,” Phytomedicine, vol. 16, no. 11, pp. 1027–1032, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. Y.-Q. Wang, M. Dai, J.-C. Zhong, and D.-K. Yin, “Paeonol inhibits oxidized low density lipoprotein-induced monocyte adhesion to vascular endothelial cells by inhibiting the mitogen activated protein kinase pathway,” Biological and Pharmaceutical Bulletin, vol. 35, no. 5, pp. 767–772, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Li, Y. H. Xie, Q. Yang et al., “Cardioprotective effect of paeonol and danshensu combination on isoproterenol-induced myocardial injury in rats,” PloS ONE, vol. 7, no. 11, Article ID e48872, 2012. View at Google Scholar · View at Scopus
  12. Q. Yang, S. Wang, Y. Xie et al., “Effect of Salvianolic acid b and paeonol on blood lipid metabolism and hemorrheology in myocardial schemia rabbits induced by pituitruin,” International Journal of Molecular Sciences, vol. 11, no. 10, pp. 3696–3704, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Gaur, K. S. Yadav, R. K. Verma, N. P. Yadav, and R. S. Bhakuni, “In vivo anti-diabetic activity of derivatives of isoliquiritigenin and liquiritigenin,” Phytomedicine, vol. 21, no. 4, pp. 415–422, 2014. View at Publisher · View at Google Scholar
  14. A. M. Mahmoud, M. B. Ashour, A. Abdel-Moneim, and O. M. Ahmed, “Hesperidin and naringin attenuate hyperglycemia-mediated oxidative stress and proinflammatory cytokine production in high fat fed/streptozotocin-induced type 2 diabetic rats,” Journal of Diabetes and its Complications, vol. 26, no. 6, pp. 483–490, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. M. A. Alam, K. Kauter, and L. Brown, “Naringin improves diet-induced cardiovascular dysfunction and obesity in high carbohydrate, high fat diet-fed rats,” Nutrients, vol. 5, no. 3, pp. 637–650, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Hasanein, “Glabridin as a major active isoflavan from Glycyrrhiza glabra (licorice) reverses learning and memory deficits in diabetic rats,” Acta Physiologica Hungarica, vol. 98, no. 2, pp. 221–230, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Lee, S. S. Choe, H. Jang et al., “AMPK activation with glabridin ameliorates adiposity and lipid dysregulation in obesity,” Journal of Lipid Research, vol. 53, no. 7, pp. 1277–1286, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Liu, L. Feng, D. Ma et al., “Neuroprotective effect of paeonol on cognition deficits of diabetic encephalopathy in streptozotocin-induced diabetic rat,” Neuroscience Letters, vol. 549, pp. 63–68, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. N. N. Song, J. B. Wu, X. B. Wei, H. S. Guan, and X. M. Zhang, “Paeonol attenuates oxygen-glucose deprivation injury and inhibits NMDA receptor activation of cultured rat hippocampal neurons,” Yao Xue Xue Bao, vol. 44, pp. 1228–1232, 2009. View at Google Scholar
  20. Y. W. Kim, H. E. Kang, M. G. Lee et al., “Liquiritigenin, a flavonoid aglycone from licorice, has a choleretic effect and the ability to induce hepatic transporters and phase-II enzymes,” American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 296, no. 2, pp. G372–G381, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Li, L. Fan, G. Sun et al., “Paeonol inhibits tumor growth in gastric cancer in vitro and in vivo,” World Journal of Gastroenterology, vol. 16, no. 35, pp. 4483–4490, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. X. Yang, L. Zhang, S. Jiang, P. Gong, and F. Zeng, “Effect of dauricine on apoptosis and expression of apoptogenic protein after transient focal cerebral ischemia-reperfusion injury in rats,” Zhongguo Zhong Yao Za Zhi, vol. 34, no. 1, pp. 78–83, 2009. View at Google Scholar · View at Scopus
  23. H. Jin, S. Shen, X. Chen, D. Zhong, and J. Zheng, “CYP3A-mediated apoptosis of dauricine in cultured human bronchial epithelial cells and in lungs of CD-1 mice,” Toxicology and Applied Pharmacology, vol. 261, no. 3, pp. 248–254, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Punvittayagul, R. Wongpoomchai, S. Taya, and W. Pompimon, “Effect of pinocembrin isolated from Boesenbergia pandurata on xenobiotic-metabolizing enzymes in rat liver,” Drug Metabolism Letters, vol. 5, no. 1, pp. 1–5, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Wang, Y. Li, X. Zu, M. Chen, and L. Qi, “Dauricine can inhibit the activity of proliferation of urinary tract tumor cells,” Asian Pacific Journal of Tropical Medicine, vol. 5, no. 12, pp. 973–976, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. Z. Yang, C. Li, X. Wang et al., “Dauricine induces apoptosis, inhibits proliferation and invasion through inhibiting NF-κB signaling pathway in colon cancer cells,” Journal of Cellular Physiology, vol. 225, no. 1, pp. 266–275, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. X. D. Tang, X. Zhou, and K. Y. Zhou, “Dauricine inhibits insulin-like growth factor-I-induced hypoxia inducible factor 1α protein accumulation and vascular endothelial growth factor expression in human breast cancer cells,” Acta Pharmacologica Sinica, vol. 30, no. 5, pp. 605–616, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. A. McLachlan, N. Kekre, J. McNulty, and S. Pandey, “Pancratistatin: A natural anti-cancer compound that targets mitochondria specifically in cancer cells to induce apoptosis,” Apoptosis, vol. 10, no. 3, pp. 619–630, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Griffin, A. Karnik, J. McNulty, and S. Pandey, “Pancratistatin selectively targets cancer cell mitochondria and reduces growth of human colon tumor xenografts,” Molecular Cancer Therapeutics, vol. 10, no. 1, pp. 57–68, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Griffin, J. McNulty, and S. Pandey, “Pancratistatin induces apoptosis and autophagy in metastatic prostate cancer cells,” International Journal of Oncology, vol. 38, no. 6, pp. 1549–1556, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. E. J. Yang, J. S. Min, H. Y. Ku et al., “Isoliquiritigenin isolated from Glycyrrhiza uralensis protects neuronal cells against glutamate-induced mitochondrial dysfunction,” Biochemical and Biophysical Research Communications, vol. 421, no. 4, pp. 658–664, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. H. K. Lee, E. Yang, J. Y. Kim, K. Song, and Y. H. Seong, “Inhibitory effects of glycyrrhizae radix and its active component, isoliquiritigenin, on Aβ(25-35)-induced neurotoxicity in cultured rat cortical neurons,” Archives of Pharmacal Research, vol. 35, no. 5, pp. 897–904, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. M. Kim, T. H. Kim, Y. W. Kim et al., “Inhibition of liver X receptor-α-dependent hepatic steatosis by isoliquiritigenin, a licorice antioxidant flavonoid, as mediated by JNK1 inhibition,” Free Radical Biology & Medicine, vol. 49, no. 11, pp. 1722–1734, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. X. Yuan, B. Yu, Y. Wang et al., “Involvement of endoplasmic reticulum stress in isoliquiritigenin-induced SKOV-3 cell apoptosis,” Recent Patents on Anti-Cancer Drug Discovery, vol. 8, no. 2, pp. 191–199, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. X. Yuan, B. Zhang, N. Chen et al., “Isoliquiritigenin treatment induces apoptosis by increasing intracellular ROS levels in HeLa cells,” Journal of Asian Natural Products Research, vol. 14, no. 8, pp. 789–798, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. X. Zhang, E. D. Yeung, J. Wang et al., “Isoliquiritigenin, a natural anti-oxidant, selectively inhibits the proliferation of prostate cancer cells,” Clinical and Experimental Pharmacology and Physiology, vol. 37, no. 8, pp. 841–847, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. X. Chen, B. Zhang, X. Yuan et al., “Isoliquiritigenin-induced differentiation in mouse melanoma B16F0 cell line,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 534934, 11 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Chen, B. Zhang, X. Yuan et al., “Isoliquiritigenin-induced effects on Nrf2 mediated antioxidant defence in the HL-60 cell monocytic differentiation,” Cell Biology International, vol. 37, no. 11, pp. 1215–1224, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Gopinath and G. Sudhandiran, “Naringin modulates oxidative stress and inflammation in 3-nitropropionic acid-induced neurodegeneration through the activation of nuclear factor-erythroid 2-related factor-2 signalling pathway,” Neuroscience, vol. 227, pp. 134–143, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Gopinath, D. Prakash, and G. Sudhandiran, “Neuroprotective effect of naringin, a dietary flavonoid against 3-Nitropropionic acid-induced neuronal apoptosis,” Neurochemistry International, vol. 59, no. 7, pp. 1066–1073, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. Y.-L. Luo, C.-C. Zhang, P.-B. Li et al., “Naringin attenuates enhanced cough, airway hyperresponsiveness and airway inflammation in a guinea pig model of chronic bronchitis induced by cigarette smoke,” International Immunopharmacology, vol. 13, no. 3, pp. 301–307, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Chen, Y. Nie, Y. Luo et al., “Protective effects of naringin against paraquat-induced acute lung injury and pulmonary fibrosis in mice,” Food and Chemical Toxicology, vol. 58, pp. 133–140, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. E. Ramesh and A. A. Alshatwi, “Naringin induces death receptor and mitochondria-mediated apoptosis in human cervical cancer (SiHa) cells,” Food and Chemical Toxicology, vol. 51, no. 1, pp. 97–105, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Li, B. Yang, J. Huang et al., “Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway,” Toxicology Letters, vol. 220, no. 3, pp. 219–228, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. P. L. Sequetto, T. T. Oliveira, I. R. Maldonado et al., “Naringin accelerates the regression of pre-neoplastic lesions and the colorectal structural reorganization in a murine model of chemical carcinogenesis,” Food and Chemical Toxicology, vol. 64, pp. 200–209, 2014. View at Publisher · View at Google Scholar
  46. Y. Nie, H. Wu, P. Li et al., “Anti-inflammatory effects of naringin in chronic pulmonary neutrophilic inflammation in cigarette smoke-exposed rats,” Journal of Medicinal Food, vol. 15, no. 10, pp. 894–900, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. G. I. Harisa, “Naringin mitigates erythrocytes aging induced by Paclitaxel: an in vitro study,” Journal of Biochemical and Molecular Toxicology, vol. 28, no. 3, pp. 129–136, 2014. View at Publisher · View at Google Scholar
  48. X. Q. Yu, C. C. Xue, Z. W. Zhou et al., “In vitro and in vivo neuroprotective effect and mechanisms of glabridin, a major active isoflavan from Glycyrrhiza glabra (licorice),” Life Sciences, vol. 82, no. 1-2, pp. 68–78, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. Y. L. Hsu, L. Y. Wu, M. F. Hou et al., “Glabridin, an isoflavan from licorice root, inhibits migration, invasion and angiogenesis of MDA-MB-231 human breast adenocarcinoma cells by inhibiting focal adhesion kinase/Rho signaling pathway,” Molecular Nutrition & Food Research, vol. 55, no. 2, pp. 318–327, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. J. H. Yang, B. Y. Shin, J. Y. Han et al., “Isorhamnetin protects against oxidative stress by activating Nrf2 and inducing the expression of its target genes,” Toxicology and Applied Pharmacology, vol. 274, pp. 293–301, 2014. View at Google Scholar
  51. C. Shi, L. Y. Fan, Z. Cai, Y. Y. Liu, and C. L. Yang, “Cellular stress response in Eca-109 cells inhibits apoptosis during early exposure to isorhamnetin.,” Neoplasma, vol. 59, no. 4, pp. 361–369, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Boubaker, M. B. Sghaier, I. Skandrani, K. Ghedira, and L. Chekir-Ghedira, “Isorhamnetin 3-O-robinobioside from Nitraria retusa leaves enhance antioxidant and antigenotoxic activity in human chronic myelogenous leukemia cell line K562,” BMC Complementary and Alternative Medicine, vol. 12, article 135, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. L. Ramachandran, K. A. Manu, M. K. Shanmugam et al., “Sethi G.Isorhamnetin inhibits proliferation and invasion and induces apoptosis through the modulation of peroxisome proliferator-activated receptor? activation pathway in gastric cancer,” The Journal of Biological Chemistry, vol. 287, pp. 38028–38040, 2012. View at Google Scholar
  54. K. Seo, J. H. Yang, S. C. Kim, S. K. Ku, S. H. Ki, and S.M. Shin, “The antioxidant effects of isorhamnetin contribute to inhibit COX-2 expression in response to inflammation: a potential role of HO-1,” Inflammation, vol. 37, no. 3, pp. 712–722, 2014. View at Google Scholar
  55. C. Guo, L. Tong, M. Xi, H. Yang, H. Dong, and A. Wen, “Neuroprotective effect of calycosin on cerebral ischemia and reperfusion injury in rats,” Journal of Ethnopharmacology, vol. 144, no. 3, pp. 768–774, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Chen, X. Zhao, Y. Ye, Y. Wang, and J. Tian, “Estrogen receptor beta-mediated proliferative inhibition and apoptosis in human breast cancer by calycosin and formononetin,” Cellular Physiology and Biochemistry, vol. 32, no. 6, pp. 1790–1797, 2013. View at Publisher · View at Google Scholar
  57. M. Gao, R. Liu, S. Y. Zhu, and G. H. Du, “Acute neurovascular unit protective action of pinocembrin against permanent cerebral ischemia in rats,” Journal of Asian Natural Products Research, vol. 10, no. 6, pp. 551–558, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. J. Qian, “Cardiovascular pharmacological effects of bisbenzylisoquinoline alkaloid derivatives,” Acta Pharmacologica Sinica, vol. 23, no. 12, pp. 1086–1092, 2002. View at Google Scholar · View at Scopus
  59. D. Kong, F. Zhang, D. Wei et al., “Paeonol inhibits hepatic fibrogenesis via disrupting nuclear factor-κB pathway in activated stellate cells: in vivo and in vitro studies,” Journal of Gastroenterology and Hepatology, vol. 28, no. 7, pp. 1223–1233, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. M. A. S. Kumar, M. Nair, P. S. Hema, J. Mohan, and T. R. Santhoshkumar, “Pinocembrin triggers Bax-dependent mitochondrial apoptosis in colon cancer cells,” Molecular Carcinogenesis, vol. 46, no. 3, pp. 231–241, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. R. Li, M. Guo, G. Zhang, X. Xu, and Q. Li, “Nicotiflorin reduces cerebral ischemic damage and upregulates endothelial nitric oxide synthase in primarily cultured rat cerebral blood vessel endothelial cells,” Journal of Ethnopharmacology, vol. 107, no. 1, pp. 143–150, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. A. Prakash, B. Shur, and A. Kumar, “Naringin protects memory impairment and mitochondrial oxidative damage against aluminum-induced neurotoxicity in rats,” International Journal of Neuroscience, vol. 123, no. 9, pp. 636–645, 2013. View at Publisher · View at Google Scholar · View at Scopus
  63. R. Li, M. Guo, G. Zhang, X. Xu, and Q. Li, “Neuroprotection of nicotiflorin in permanent focal cerebral ischemia and in neuronal cultures,” Biological and Pharmaceutical Bulletin, vol. 29, no. 9, pp. 1868–1872, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. R. T. Liu, L. B. Zou, J. Y. Fu, and Q. J. Lu, “Effects of liquiritigenin treatment on the learning and memory deficits induced by amyloid β-peptide (25–35) in rats,” Behavioural Brain Research, vol. 210, no. 1, pp. 24–31, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. X. H. Dai, H. E. Li, C. J. Lu et al., “Liquiritigenin prevents Staphylococcus aureus-mediated lung cell injury via inhibiting the production of α-hemolysin,” Journal of Asian Natural Products Research, vol. 15, no. 4, pp. 390–399, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Zhou, H. Higo, and Y. Cai, “Inhibition of hepatoma 22 tumor by liquiritigenin,” Phytotherapy Research, vol. 24, no. 6, pp. 827–833, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. Y. W. Kim, R. J. Zhao, S. J. Park et al., “Anti-inflammatory effects of liquiritigenin as a consequence of the inhibition of NF-κB-dependent iNOS and proinflammatory cytokines production,” British Journal of Pharmacology, vol. 154, no. 1, pp. 165–173, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. E. M. Choi, K. S. Suh, and Y. S. Lee, “Liquiritigenin restores osteoblast damage through regulating oxidative stress and mitochondrial dysfunction,” Phytotherapy Research, vol. 28, no. 6, pp. 880–886, 2014. View at Publisher · View at Google Scholar
  69. X. C. Lin, Y. Y. Chen, S. T. Bai, J. Zheng, and L. Tong, “Protective effect of licoflavone on gastric mucosa in rats with chronic superficial gastritis,” Nan Fang Yi Ke Da Xue Xue Bao, vol. 33, pp. 299–304, 2013. View at Google Scholar
  70. H. Haraguchi, J. Inoue, Y. Tamura, and K. Mizutani, “Antioxidative components of Psoralea corylifolia (Leguminosae),” Phytotherapy Research, vol. 16, no. 6, pp. 539–544, 2002. View at Publisher · View at Google Scholar · View at Scopus
  71. R. Nishimura, K. Tabata, M. Arakawa et al., “Isobavachalcone, a chalcone constituent of Angelica keiskei, induces apoptosis in neuroblastoma,” Biological and Pharmaceutical Bulletin, vol. 30, no. 10, pp. 1878–1883, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. J. Lee, S. Won, C. Chao et al., “Morusin induces apoptosis and suppresses NF-κB activity in human colorectal cancer HT-29 cells,” Biochemical and Biophysical Research Communications, vol. 372, no. 1, pp. 236–242, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. L. Wang, H. Guo, L. Yang et al., “Morusin inhibits human cervical cancer stem cell growth and migration through attenuation of NF-κB activity and apoptosis induction,” Molecular and Cellular Biochemistry, vol. 379, no. 1-2, pp. 7–18, 2013. View at Publisher · View at Google Scholar · View at Scopus
  74. M. M. Rafi, R. T. Rosen, A. Vassil et al., “Modulation of bcl-2 and cytotoxicity by licochalcone-A, a novel estrogenic flavonoid,” Anticancer Research, vol. 20, no. 4, pp. 2653–2658, 2000. View at Google Scholar · View at Scopus
  75. X. Yuan, D. Li, H. Zhao et al., “Licochalcone A-induced human bladder cancer T24 cells apoptosis triggered by mitochondria dysfunction and endoplasmic reticulum stress,” BioMed Research International, vol. 2013, Article ID 474272, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  76. J. Kim, E. K. Shin, J. H. Park, Y. H. Kim, and J. H. Y. Park, “Antitumor and antimetastatic effects of licochalcone A in mouse models,” Journal of Molecular Medicine, vol. 88, no. 8, pp. 829–838, 2010. View at Publisher · View at Google Scholar · View at Scopus
  77. X. Yuan, T. Li, E. Xiao et al., “Licochalcone B inhibits growth of bladder cancer cells by arresting cell cycle progression and inducing apoptosis,” Food and Chemical Toxicology, vol. 65, pp. 242–251, 2014. View at Google Scholar
  78. P. Akbay, A. A. Basaran, U. Undeger, and N. Basaran, “In vitro immunomodulatory activity of flavonoid glycosides from Urtica dioica L.,” Phytotherapy Research, vol. 17, no. 1, pp. 34–37, 2003. View at Publisher · View at Google Scholar · View at Scopus
  79. P. M. Amália, M. N. Possa, M. C. Augusto, and L. S. Francisca, “Quercetin prevents oxidative stress in cirrhotic rats,” Digestive Diseases and Sciences, vol. 52, no. 10, pp. 2616–2621, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. R. Liu, M. Gao, Z. Yang, and G. Du, “Pinocembrin protects rat brain against oxidation and apoptosis induced by ischemia-reperfusion both in vivo and in vitro,” Brain Research, vol. 1216, pp. 104–115, 2008. View at Publisher · View at Google Scholar · View at Scopus
  81. H.-M. Guang and G.-H. Du, “Protections of pinocembrin on brain mitochondria contribute to cognitive improvement in chronic cerebral hypoperfused rats,” European Journal of Pharmacology, vol. 542, no. 1–3, pp. 77–83, 2006. View at Publisher · View at Google Scholar · View at Scopus
  82. Y. Wang, J. Gao, Y. Miao et al., “Pinocembrin protects SH-SY5Y cells against MPP+-induced neurotoxicity through the mitochondrial apoptotic pathway,” Journal of Molecular Neuroscience, 2014. View at Google Scholar